Collegium Pharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Collegium Pharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					         Collegium Pharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and
                                     Alliances Profile
       Reference Code: GDPH45721D                                                                                                             Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Collegium Pharmaceutical, Inc. (Collegium Pharmaceutical) is a pharmaceutical and
                                                                                                              Collegium Pharmaceutical, Inc., Pharmaceuticals &
      health care service provider, based in the US. The company focuses on late-stage
                                                                                                              Healthcare, Key Facts
      development, and commercialization of prescription pharmaceuticals for the
      treatment of central nervous system (CNS), respiratory and skin related disorders.                       Web Address                        www.collegiumpharma.c
      Collegium is focused on building a portfolio of products for the treatment of chronic                                                       om
      pain that possess tamper-resistant features and provide extended-release delivery
                                                                                                               Revenue (US$ million)                             NA
      using its patent protected DETERx formulation platform. Its product pipeline includes
      COL-003, COL-172, COL-195, COL-196, and COL-171.                                                         Number of Employees                               NA
                                                                                                               GlobalData

      Financial Deals Landscape
        Collegium Pharmaceutical, Inc., Pharmaceuticals & Healthcare,                     Collegium Pharmaceutical, Inc., Pharmaceuticals &
        Deals by Type, 2007 to YTD 2013                                                   Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                          1         1     1                1
                                                                                                          1

                                                                                           No. of Deals



                                                                                                                 0                                0                  0
                                                                                                          0
                                                                                                               2007      2008   2009     2010    2011     2012   YTD
                                                                                                                                                                 2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Collegium Pharmaceutical, Inc., Pharmaceuticals &                                Collegium Pharmaceutical, Inc., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                                                                                                          5          4
                               2        2
                                                                                           No. of Deals
          No. of Deals




                         2                                                                                4
                                                                                                                                3         3           3
                                                                                                          3

                         1                                                                                2                                                      1
                                                                                                          1
                                                 0         0         0                                    0
                         0                                                                                        Ear   Central         Dermat    Over-   Immun
                             Europe   North     Asia-    Middle   South                                          Nose Nervou             ology     the-    ology
                                      Americ   Pacific    East     and                                          Throat     s                     Counte
                                        a                 and     Central                                       Disorde System                       r
                                                         Africa   Americ                                           rs                            H ealt …
                                                                    a


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals             from 2006 onwards, GlobalData
         from 2006 onwards, GlobalData




Collegium Pharmaceutical, Inc. - Pharmaceuticals & Healthcare -                                                                                  Reference Code: GDPH45721D
Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                 Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Collegium Pharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................ 3
       Collegium Pharmaceutical, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................. 5
       Collegium Pharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................ 6
       Collegium Pharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .................................. 7
       Collegium Pharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013.............................................. 8
       Collegium Pharmaceutical, Inc., Pharmaceuticals & Healthcare, Deal Details ................................................................................... 9
          Venture Financing........................................................................................................................................................................... 9
             Collegium Pharma Raises $22.5 Million In Series B Financing ................................................................................................... 9
             Collegium Pharma Raises $1 Million In Venture Financing ....................................................................................................... 11
             Collegium Pharma Secures $20 Million In Series A Financing.................................................................................................. 12
          Asset Transactions ....................................................................................................................................................................... 14
             Lupin Acquires Rights To AllerNaze From Collegium Pharma .................................................................................................. 14
       Collegium Pharmaceutical, Inc. - Key Competitors .......................................................................................................................... 16
       Key Employees ................................................................................................................................................................................ 17
       Locations And Subsidiaries .............................................................
				
DOCUMENT INFO
Description: Collegium Pharmaceutical, Inc. (Collegium Pharmaceutical) is a pharmaceutical and health care service provider, based in the US. The company focuses on late-stage development, and commercialization of prescription pharmaceuticals for the treatment of central nervous system (CNS), respiratory and skin related disorders. Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent protected DETERx formulation platform. Its product pipeline includes COL-003, COL-172, COL-195, COL-196, and COL-171. The products incorporate technologies, delivery systems and innovative regulatory strategies. Collegium Pharmaceutical is headquartered in Cumberland, Rhode Island, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.